Ben has extensive experience in leveraged finance matters with a particular focus on private equity-sponsored acquisition financings. He represents middle-market lenders, investors, sponsors, and portfolio companies in acquisition financings and related debt transactions. He advises clients throughout the entire process of a transaction from structuring to closing and beyond.
Schiff advised Altaris Capital Partners, LLC on its acquisition of Padagis LLC, formerly the generic prescription pharmaceuticals business of Perrigo Company plc, for $1.55 billion.
Altaris Capital Partners, LLC has announced that it has entered into an agreement to sell Paramit Corporation to The Tecan Group for $1 billion.
Schiff Hardin LLP represented Altaris Capital Partners, LLC, a private investment firm focused on the healthcare industry, in its agreement to acquire Perrigo Company plc’s prescription pharmaceuticals business (Rx) for $1.55 billion.
Schiff Hardin LLP represented Altaris Capital Partners, LLC, a private investment firm focused on the healthcare industry, in the majority recapitalization of Minnetronix Medical, Inc., a leading medical technology and operations partner to global medical device companies.
Schiff Hardin LLP is advising Kimball International, Inc., a leading design driven furniture manufacturer, in the acquisition of Poppin, Inc., a tech-enabled B2B commercial furniture design company, for $110 million with potential for additional contingent payments equal to $70 million.
Schiff Hardin LLP is advising Consolidated Communications Holdings, Inc., a leading broadband and business communications provider, in a proposed $425 million investment agreement with an affiliate of Searchlight Capital Partners, L.P.
Schiff Hardin LLP represented Altaris Capital Partners LLC, a private investment firm focused on the healthcare industry, in its $650 million acquisition of substantially all of Kindeva Drug Delivery from 3M Company.
Schiff Hardin LLP announced today that Ben Leese has joined as a partner in the Finance Practice Group in the New York office.